XML 53 R39.htm IDEA: XBRL DOCUMENT v3.21.1
18. Quarterly Financial Data (Tables)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Schedule of quarterly financial data (Unaudited)

Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

 

  Quarter Ended  
  Dec. 31,   Sept. 30,   Jun. 30,   Mar. 31,   Dec. 31,   Sept. 30,   Jun. 30,   Mar. 31,  
  2020   2020   2020   2020   2019   2019   2019   2019  
  (Unaudited, in thousands, except share and per share information)  
Revenues $ 4,383   $ 19,466   $ 2,118   $ 3,815   $ 688   $ 1,711   $ 5,460   $ 3,387  
Portfolio operations:                                                
Inventor royalties   506     5,772     645     426     192     776     2,623     1,353  
Contingent legal fees   564     6,609     12     234     4     35     375     177  
Patent acquisition expenses   –     –     –     –     –     –     –     –  
Litigation and licensing expenses - patents   2,186     1,001     1,459     1,037     1,160     987     1,855     3,801  
Amortization of patents   1,159     1,174     1,305     1,043     857     863     818     656  
Other portfolio expenses   –     –     (74 )   (234 )   1,581     (475 )   –     650  
Total portfolio operations   4,415     14,556     3,347     2,506     3,794     2,186     5,671     6,637  
Net portfolio income (loss)   (32 )   4,910     (1,229 )   1,309     (3,106 )   (475 )   (211 )   (3,250 )
General and administrative expenses (including non-cash stock compensation expense)   6,387     7,692     5,519     4,878     4,328     4,630     3,763     3,655  
Impairment of patent-related intangible assets   –     –     –     –     –     –     –     –  
Operating income (loss)   (6,419 )   (2,782 )   (6,748 )   (3,569 )   (7,434 )   (5,105 )   (3,974 )   (6,905 )
Total other income (expense)   86,756     41,213     12,894     (9,060 )   5,921     (2,503 )   (1,774 )   2,821  
Income (loss) before provision for income taxes   80,337     38,431     6,146     (12,629 )   (1,513 )   (7,608 )   (5,748 )   (4,084 )
Provision for income taxes   (98 )   (83 )   2     1,338     2,147     –     (9 )   (314 )
Net income (loss) including noncontrolling interests   80,239     38,348     6,148     (11,291 )   634     (7,608 )   (5,757 )   (4,398 )
Net (income) loss attributable to noncontrolling interests in subsidiaries   –     –     –     –     –     –     –     14  
Net income (loss) attributable to Acacia Research Corporation $ 80,239   $ 38,348   $ 6,148   ($ 11,291 ) $ 634   ($ 7,608 ) ($ 5,757 ) ($ 4,384 )
                                                 
Net income (loss) attributable to common shareholders - basic $ 65,180   $ 30,529   $ 4,201   $ (12,185 ) $ 327   $ (7,608 ) $ (5,757 ) $ (4,384 )
Basic income (loss) per share $ 1.34   $ 0.63   $ 0.09   ($ 0.24 ) $ 0.01   ($ 0.15 ) ($ 0.12 ) ($ 0.09 )
Weighted-average number of shares outstanding, basic   48,508,903     48,467,885     48,457,620     49,875,396     49,875,750     49,828,361     49,696,016     49,655,881  
                                                 
Net loss attributable to common stockholders - diluted $ 65,352   $ 29,204   $ 4,201   $ (12,185 ) $ (2,624 ) $ (7,608 ) $ (5,757 ) $ (4,384 )
Diluted net income (loss) per common share $ 1.33   $ 0.32   $ 0.09   ($ 0.24 ) ($ 0.05 ) ($ 0.15 ) ($ 0.12 ) ($ 0.09 )
Weighted average number of shares outstanding - diluted   49,244,141     90,624,702     49,033,824     49,875,396     54,406,835     49,828,361     49,696,016     49,655,881